ANGPTL4 and Lymphadenopathy: Importantly, in a recent targeted cis-pQTL mendelian randomization analysis (76), genetically lowered plasma ANGPTL4 levels via the ANGPTL4 p.E40K and p.Cys80 fs variants were not associated with any phenotypes related to lymphadenopathy and malabsorptive states.